We're #hiring! We are seeking a motivated Quality Assurance Specialist to lead quality and compliance across Hyfe's product portfolio. This role offers an exciting opportunity to work at the forefront of AI-powered digital health technology. See details and apply ???? https://lnkd.in/gzMr7JmT
Hyfe
医院和医疗保健
Wilmington,Delaware 3,144 位关注者
AI-powered cough-tracking & insights. Precision medicine for respiratory health
关于我们
Hyfe is the global leader in cough. Our longitudinal cough monitoring and insights capabilities are used daily by thousands of researchers, pharma, physicians and patients across the world. From remote-patient-monitoring in chronic care management, to digital biomarkers for clinical trials, we bring precision medicine and personalized approaches to respiratory health. Hyfe’s AI models are trained on the world's largest database of 25B+ data points collected from 160+ countries. Hyfe has also been validated in 46+ research trials across indications including asthma, COPD, Congestive Heart Failure and Covid.
- 网站
-
https://www.hyfe.com/
Hyfe的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 11-50 人
- 总部
- Wilmington,Delaware
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Healthcare、Wellness和AI
地点
Hyfe员工
-
Julian Atim
Clinical Development | MedTech Innovation Strategy | Global Health
-
Tamsin Chislett
CEO at Hyfe.ai | We use AI to harness the potential of cough as a vital sign.
-
Carlos J. Chaccour D.
Experienced and accomplished professional in global health, specializing in malaria and neglected tropical diseases (NTDs)
-
Joe Brew
Chief Data Scientist at hyfe.ai | We use AI to track coughs, in order to predict, manage & treat respiratory health
动态
-
Hyfe转发了
Almost 40% of all Americans suffer from a respiratory condition. That's more than 130 million people. Chances are these numbers will even trend higher ion others parts of the world where things like air quality or smoking would add additional risks. Every single one of them is coughing. And yet, in our clinical standards we have normalized the fallacy that somehow we don't need to quantify this incredibly common and critical symptom. It makes sense. People's subjective perception of their own coughing is unreliable. And using "gold standard" methods to quantify cough - sound recorders that record everything - has been seriously impractical. This is a problem that Hyfe has solved. It is now not only possible but in fact easy and convenient to measure cough in pretty much any setting. There is even a free app that anyone can use to do just that. (Image source: Pleasants RA, Heidari K, Ohar J, Donohue JF, Lugogo NL, Kanotra SM, Kraft M, Mannino DM, Strange CB. Respiratory Symptoms among US Adults: a Cross-Sectional Health Survey Study. Pulm Ther. 2022 Sep;8(3):255-268. doi: 10.1007/s41030-022-00194-9. Epub 2022 Jul 6. PMID: 35794458; PMCID: PMC9458821).
-
-
We're #hiring! ??fully remote ???? fluent in Japanese Hyfe has commenced an exciting multi-year partnership with a pharma company to develop and commercialize the world’s first digital therapeutic (DTx). We are seeking a Product Manager to drive the ongoing development of the respiratory health DTx app for the Japanese market. This individual will work cross-functionally with the design team, clinical experts, engineers, and the regulatory team to build an engaging, clinically validated, and user-friendly product, that will be available for prescription in Japan. You can find the details and apply below ???? https://lnkd.in/dT6PyJhx
-
Thank you to MediaPost for highlighting our partnership with KYORIN Pharmaceutical Co., Ltd. and the digital therapeutics we're developing. In the article, Pharma & Health Insider asks: How does behavioral cough suppression therapy (BCST) work? Our Chief Experience Officer Reid Moorsmith explains: ????? ???? ?? ???????? ????????-?????????????????? ???????????????????? ?????????????? ?????????????????? ??????????????????, ?????????? ?????????????????????? ???????????????????? ?????? ???????????????? ???????? ?????????????? ???????????? ?????? ???????? ???????????????????? ?????????????? ?????????? ???? ?????????? ???? ?????????????? ??????????. ??????????????????????????, ????’?? ???????? ?????????????? ???? ?????????? 200 ???????????? ???????????????? ????????????????????????. ?????? ???????? ?????? ????. Slovarp Laurie , ??????’?? ?????? ???? ?????? ??????????’?? ?????????????? ?????????????? ???? ????????. ???? ???????? ???? ?????? ???????? ?????????????? ???? ?????? ???????? ???? ???? ?????? ???? ???????? ???? ???????????? ????????????????????. Read more in the full article: ?? https://lnkd.in/d52yAz_b
-
Is your wearable device missing a key health indicator? Heart rate, sleep quality, and oxygen levels are common metrics - but what about cough? Hyfe's new whitepaper explores how continuous cough tracking can transform health outcomes by: - Predicting exacerbations - Improving chronic disease management - Unlocking deeper insights for clinical trials and remote patient monitoring Tap into the full potential of wearable health data. ?? Find the link in the comments below
-
-
Hyfe转发了
How do you bring digital therapeutics to the market? I discussed it with the Chief Medical Officer of Hyfe, Dr. Peter Small. The full interview is available on our exclusive Patreon channel: https://lnkd.in/evGbFx4p ??. ?????? ???? ?????? ?????????????? ???????????????????????? ???????????? ?????? ?? ?????????????? ??????????????????????? - Assessing DTx/SaMD requirements from regulators based on past experience - Clinical trials to demonstrate safety, efficacy, and cost-effectiveness - Compliance with relevant software-as-a-medical-device (SaMD) regulations, and data privacy and security requirements, which are evaluated as part of the SaMD review -? Regulatory clearance or approval from bodies like the FDA in the US, EMA in EU, PMDA in Japan -? Peer-reviewed dissemination / real-world evidence to reinforce clinical credibility and facilitate reimbursement pathways -? Working with KOLs to establish new clinical standards - Educating and training clinicians working with chronic cough patients, so they can properly prescribe the DTx
-
-
What’s it like working at Hyfe? Just ask Stephanie Swift! At Hyfe, we don’t believe in the typical 9-to-5. Every day is different, and flexibility isn’t just a perk - it’s how we work. ???? Steph, our Research Operations Manager, brings years of experience managing clinical trials, leading research projects, and collaborating with global teams. From overseeing vaccine trials with thousands of participants to co-founding a research community of 80+ clinicians, she knows how to make an impact - no matter where she’s working from. Steph shared with us what Life at Hyfe looks like for her ?? ?? Work from anywhere, literally – from research meetings to operational logistics, Steph has even worked from Ottawa's frozen canal, the world’s longest ice rink! ???? ?? Flexibility that fits your life – Whether it’s learning French, skiing, or visiting family in another country, remote work at Hyfe means life comes first. ?? A culture that values ideas – Steph’s advice for new hires? “Don’t be afraid to share ideas, thoughts, and solutions.” We’re all about collaboration and innovation. ?? Dream office? Anywhere with a big screen! (And maybe Valencia, Spain ????) Sounds like your kind of workplace? We’re growing! Check out our open roles ???? and join us in redefining how (and where) work happens. #LifeAtHyfe #RemoteWork #Hiring #FlexibleWork #WorkFromAnywhere
-
We're #hiring! Hyfe is looking for a Research Project Manager to oversee the delivery of cutting-edge cough-monitoring services for pharmaceutical and academic studies. This role offers an exciting opportunity to work at the forefront of digital health technology in clinical research. Find the details and apply here ?? https://lnkd.in/d7MgYiQW
-
We’re thrilled to be featured in STAT by Mario Aguilar, highlighting our partnership with KYORIN Pharmaceutical Co., Ltd. to develop a digital therapeutic for chronic cough! Japan is just the beginning. As we develop this solution with Kyorin, we're exploring opportunities to bring the DTx to the US and other markets - expanding access to millions who suffer from chronic cough. A big thank you to STAT and Mario for covering this important milestone. We’re excited about the future of digital respiratory therapeutics! ?? Read the full feature here: https://lnkd.in/ddHMhJ44
-
-
We appreciate the mention! We're proud to be working with KYORIN Pharmaceutical Co., Ltd. to bring a new option for chronic cough patients in Japan. Digital therapeutics are opening up new possibilities in respiratory care, and we’re glad to be part of the movement!
LinkedIn ‘Top Voice’ >> Follow for the Latest Trends, Insights, and Expert Analysis in Digital Health & AI
The Pharma Five: February’s Leading Digital Health Collaborations >> ??Shionogi & Co., Ltd secured Japanese approval for the ADHD digital therapeutic EndeavorRide, licensed from Akili targeting a market with limited access to stimulant medications and aiming to integrate digital tools with its broader healthcare-as-a-service model. ??Merck’s international arm, MSD made its first Asia Pacific health tech investment by backing Thailand-based HD, whose online marketplace connects users with healthcare providers, leverages AI for customer interactions, and is already a key channel for MSD’s HPV vaccine sales in Southeast Asia ??Novartis and Dawn Health launch Cora BC, a breast cancer support app enhancing patient tracking, adherence, and communication with healthcare teams. Rolling out first in Germany, it will expand globally, building on their past digital health collaborations. ??Daewoong Pharmaceutical and Seers secure Korea’s first insurance reimbursement for thynC, an AI-powered remote monitoring system with wearable biosensors, enhancing patient safety and hospital efficiency ??Hyfe partners with KYORIN Pharmaceutical Co., Ltd. to launch the world's first prescription digital therapeutic (DTx) for chronic cough in Japan, leveraging AI-powered cough monitoring and Behavioral Cough Suppression Therapy (BCST) with higher efficacy than conventional medications ??Links to relevant articles in comments #DigitalHealth #DTx #Pharma
-